Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-05 1:26 pm Purchase | 2025-09-30 | 13G | Cabaletta Bio, Inc. CABA | Jennison Associates LLC | 12,584,537 8.900% | 2,477,370 (+24.51%) | Filing History |
| 2025-08-14 5:29 pm Purchase | 2025-06-30 | 13G | Cabaletta Bio, Inc. CABA | Alyeska Investment Group, L.P. | 8,904,367 9.900% | 8,904,367 (New Position) | Filing History |
| 2025-08-14 4:00 pm Purchase | 2025-06-30 | 13G | Cabaletta Bio, Inc. CABA | Bain Capital Life Sciences Opportunities III, LP | 9,677,125 9.990% | 6,916,237 (+250.51%) | Filing History |
| 2025-08-14 3:02 pm Purchase | 2025-06-30 | 13G | Cabaletta Bio, Inc. CABA | Cormorant Asset Management, LP | 5,000,000 5.470% | 5,000,000 (New Position) | Filing History |
| 2025-08-12 09:04 am Purchase | 2025-06-30 | 13G | Cabaletta Bio, Inc. CABA | Adage Capital Management, L.P. | 9,002,580 9.990% | 5,368,105 (+147.70%) | Filing History |
| 2025-08-11 4:27 pm Purchase | 2025-06-30 | 13G | Cabaletta Bio, Inc. CABA | Nichtberger Steven | 3,034,499 3.300% | 365,743 (+13.70%) | Filing History |
| 2025-08-06 4:15 pm Purchase | 2025-06-30 | 13G | Cabaletta Bio, Inc. CABA | Jennison Associates LLC | 10,107,167 7.200% | 7,595,114 (+302.35%) | Filing History |
| 2025-08-06 2:19 pm Purchase | 2025-06-30 | 13G | Cabaletta Bio, Inc. CABA | PRUDENTIAL FINANCIAL INC PRU | 10,391,167 7.400% | 7,592,304 (+271.26%) | Filing History |
| 2025-07-29 11:23 am Purchase | 2025-06-30 | 13G | Cabaletta Bio, Inc. CABA | The Vanguard Group | 3,450,727 3.830% | 897,017 (+35.13%) | Filing History |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | Cabaletta Bio, Inc. CABA | BlackRock Inc. BLK | 894,647 1.000% | -2,502,613 (-73.67%) | Filing History |
| 2025-06-20 5:22 pm Purchase | 2025-06-12 | 13G | Cabaletta Bio, Inc. CABA | Citadel Advisors LLC | 4,818,560 5.200% | 4,721,158 (+4847.09%) | Filing History |
| 2025-02-05 1:23 pm Sale | 2024-12-31 | 13G | Cabaletta Bio, Inc. CABA | BlackRock Inc. BLK | 3,397,260 7.000% | -1,011,745 (-22.95%) | Filing History |
| 2024-12-06 4:05 pm Sale | 2024-11-30 | 13G | Cabaletta Bio, Inc. CABA | Alger Associates, Inc. | 1,326,193 2.700% | -2,793,201 (-67.81%) | Filing History |
| 2024-12-05 4:50 pm Sale | 2024-12-05 | 13G | Cabaletta Bio, Inc. CABA | PRUDENTIAL FINANCIAL INC PRU | 2,798,863 5.700% | -2,856,857 (-50.51%) | Filing History |
| 2024-12-05 3:36 pm Sale | 2024-11-30 | 13G | Cabaletta Bio, Inc. CABA | Jennison Associates LLC | 2,512,053 5.100% | -2,658,182 (-51.41%) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | Venrock Healthcare Capital Partners III, L.P. | 1,590,696 3.300% | -973,256 (-37.96%) | Filing History |
| 2024-11-14 4:02 pm Purchase | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | Alger Associates, Inc. | 4,119,394 8.400% | 792,993 (+23.84%) | Filing History |
| 2024-11-14 1:28 pm Purchase | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | T. Rowe Price Investment Management, Inc. | 3,673,724 7.500% | 3,673,724 (New Position) | Filing History |
| 2024-11-12 1:25 pm Unchanged | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | The Vanguard Group | 2,553,710 5.220% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | Adage Capital Management, L.P. | 3,634,475 7.430% | 3,634,475 (New Position) | Filing History |